The funding opportunity RFA-IP-18-000 is a cooperative agreement offered by the Centers for Disease Control and Prevention (CDC), under the U.S. Department of Health and Human Services. This opportunity falls within the Injury Prevention and Control Research and State and Community Based Programs funding stream, cataloged under Assistance Listing 93.136. The CDC operates as the nation’s leading public health agency, responsible for conducting critical scientific research and providing guidance on disease prevention and health promotion.
This opportunity is structured as a discretionary cooperative agreement, indicating a substantial level of involvement from CDC staff in the implementation of awarded projects. The grant supports initiatives within the broad scope of health-related activities, with a specific focus on injury prevention and control. Applicants are instructed to submit Type 6 applications, which typically relate to changes or supplements in existing cooperative agreements, suggesting that this opportunity may support continuations or administrative supplements of prior awards.
Eligibility is open to a wide range of entities, including states, universities, counties, small businesses, and nonprofit organizations. This inclusive scope allows for both public institutions and private sector contributors to engage in research and community-based programs that align with CDC’s mission. The application does not require cost-sharing or matching funds, removing a potential financial barrier for applicants and broadening accessibility.
Applications must be submitted through Grants.gov, and the portal provides all necessary submission forms and guidance. Interested applicants should refer to the full announcement for specific instructions. The posted date of the opportunity is October 20, 2023, and while the original closing date was listed as October 13, 2025, it has since been updated to September 30, 2030. The number of anticipated awards is 100, though no total funding or per-award ceilings are specified, indicating that awards may be variable or contingent on further determination.
Linton C. Browning serves as the primary contact for applicants encountering access or submission issues. He can be reached via email at lbrowning@cdc.gov or by phone at 770-488-2756. The program does not currently indicate any recurring cadence, suggesting that submission is a one-time or ad hoc opportunity unless otherwise specified in future updates.
